Related Experiment Video
Updated: Aug 4, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Pulmonary function changes associated with an air pollution episode in January 1987
JAPCA
|November 1, 1989
Summary
Air pollution, including sulfur dioxide (SO2), negatively impacted children's lung function during a 1987 European episode. Lung function deficits persisted for weeks after pollution levels returned to normal.
Area of Science:
- Environmental Health
- Pediatric Pulmonology
- Air Quality Science
Background:
- A significant air pollution episode occurred in central and western Europe in January 1987.
- Elevated levels of sulfur dioxide (SO2), nitrogen dioxide (NO2), black smoke, and sulfates were recorded.
- The Netherlands experienced peak 24-hour average SO2 concentrations near 300 µg/m³.
Purpose of the Study:
- To assess the impact of the 1987 air pollution episode on children's pulmonary function.
- To evaluate the recovery of lung function following the pollution event.
Main Methods:
- Pulmonary function tests (FVC, FEV1, PEF, MMEF) were conducted on children aged 6-12.
- Measurements were taken before, during, and up to 3.5 weeks after the pollution episode.
- A validated growth model estimated pulmonary function changes relative to baseline.
Main Results:
- A decline in pulmonary function (FVC, FEV1, PEF) was observed starting on the last day of the pollution episode.
- Two weeks post-episode, significant decreases in FVC, FEV1, PEF, and MMEF were noted.
- A deficit in FVC and FEV1 persisted 3.5 weeks after the episode.
Conclusions:
- The 1987 European air pollution episode adversely affected pediatric pulmonary function.
- Lung function impairment was evident during and after the event, with some deficits lingering.
- This highlights the potential long-term respiratory health consequences of acute air pollution exposure in children.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...